Document Classification

Section Type: RESULTS

Text: Compared with placebo, pioglitazone therapy was associated with an increase in weight (mean change, -0. 55 vs +2. 77 kg ; P =. 04) and a reduction in glucose (+0. 4 vs -0. 1 mmol/L ; P =. 02), HbA1c (+0. 16 % vs -0. 18 % ; P =. 006), insulin C peptide level (+42 vs -78 pmol/L ; P =. 02), alanine aminotransferase level (-10. 9 vs -36. 2 u/L ; P =. 009), gamma-glutamyltransferase level (-9. 4 vs -41. 2 u/L ; P =. 002), and ferritin (-11. 3 vs -90. 5 microg/L ; P =. 01).